Monday, 21 September 2020


German vaccine delivery company enters China

03 May 2013 | News | By BioSpectrum Bureau

Singapore: German company Injex Pharma registered Injex30 needle free injection system with the Chinese State Food and Drug Administration (SFDA). The company's application is supported by its exclusive distributor Hangzhou Hema Medical Equipment.

SFDA is responsible for regulating the market access of medical devices in China. The arduous approval process took more than 1.5 years and has required a detailed documentation.


Sign up for the editor pick and get articles like this delivered right to your inbox.

Editors Pick
+Country Code-Phone Number(xxx-xxxxxxx)


Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account




Podcast

 

Survey Box

Should we be cautious of viewing COVID-19 vaccine as silver bullet?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls